Feasibility study of new method of diagnostic and prediction of painful cipn
Ended Project Grant Awarded Last action
- Award ID
- R43CA206796
- Recipient
-
Lasmed LTD. Liability CO. UEI NJC6SRVWF8M4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA206796?
R43CA206796 was awarded to Lasmed LTD. Liability CO. by National Cancer Institute (National Institutes of Health) on August 1, 2017.
How much is award R43CA206796 worth?
$300,000 has been obligated on R43CA206796.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award